amble semaglutide – amble health semaglutide Thinking about

ABOUT THE SERIES This webinar series features a different topic each month to educate and provide resources for both patients and practicing providers

Utilization Management Call Center: The Center will be closed with on-call services available by calling 1- 866-500-4571

66 , 486501 (2010) Adams, P

Education topics may include adherence to medications, dietary potassium intake, and scheduled blood tests (for potassium monitoring) and discussions on: Sick-day management advice Importance of informing health-care team about any changes in medical conditions and medications Avoidance of excessive fist clenching during blood collection and doing blood tests immediately after potassium ingestion, if possible Conclusion Hyperkalemia is common in individuals with CKD and diabetes, and is associated with increased risk for mortality, cardiovascular events, hospitalizations, and intensive care unit admissions

This acceleration coincided with surging demand for semaglutide and tirzepatide, two therapies that have become synonymous with the new era of diabetes and obesity treatment